Recombinant Human PSMB9 Protein，His

PSMB9, also known as proteasome subunit beta type-9, is a crucial component of the 26S proteasome, a multi-subunit complex responsible for degrading ubiquitinated proteins, thereby regulating various cellular processes, including the cell cycle, apoptosis, and immune responses. The study of PSMB9 has gained significant attention due to its role in the generation of antigenic peptides for major histocompatibility complex (MHC) class I molecules, which are essential for cytotoxic T-cell recognition and response in adaptive immunity. Additionally, PSMB9 is implicated in various diseases, including cancer, where its expression levels can influence tumor progression and immune evasion. Researchers have focused on the recombinant production of PSMB9 to better understand its structure, function, and interaction with other proteasome subunits and inhibitors. The recombinant protein can be used in biochemical assays to study its role in proteasomal activity and its effect on antigen processing. Furthermore, the therapeutic potential of targeting PSMB9 in cancer immunotherapy and treatment of autoimmune diseases underscores the need for advanced research and characterization of this protein, which may lead to novel strategies for disease intervention and improving immune responses. Overall, the exploration of PSMB9 as a recombinant protein holds promise for enhancing our understanding of proteasome function and its implications in health and disease.